azathioprine has been researched along with Immunoblastic Large-Cell Lymphoma in 1 studies
Azathioprine: An immunosuppressive agent used in combination with cyclophosphamide and hydroxychloroquine in the treatment of rheumatoid arthritis. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), this substance has been listed as a known carcinogen. (Merck Index, 11th ed)
azathioprine : A thiopurine that is 6-mercaptopurine in which the mercapto hydrogen is replaced by a 1-methyl-4-nitroimidazol-5-yl group. It is a prodrug for mercaptopurine and is used as an immunosuppressant, prescribed for the treatment of inflammatory conditions and after organ transplantation and also for treatment of Crohn's didease and MS.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hagenah, GC | 1 |
Wündisch, T | 1 |
Eckstein, E | 1 |
Zimmermann, S | 1 |
Holst, F | 1 |
Grimm, W | 1 |
Neubauer, A | 1 |
Lohoff, M | 1 |
1 other study available for azathioprine and Immunoblastic Large-Cell Lymphoma
Article | Year |
---|---|
[Sepsis-like disease in an immunocompromised patient with a travel history to Mallorca].
Topics: Adult; Animals; Azathioprine; Biopsy; Bone Marrow; Colectomy; Colitis, Ulcerative; Colon; Colonic Ne | 2007 |